Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,145.80
-38.90 (-3.28%)
Oct 7, 2026, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 158.97 billion as of October 7, 2026. That makes Eris Lifesciences the world's 7,713th most valuable company and 439th in India. Its market cap has decreased by 27.38% in one year.
Market Cap
158.97B
Enterprise Value
181.81B
Revenue
32.12B
Global Rank
Country Rank
#439 India
PE Ratio
25.29
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 158.97B, an increase of 92.21%. That is a compound annual growth rate of 7.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 158.97B | -22.49% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 363.81B |
| Wockhardt | 349.42B |
| Piramal Pharma | 269.40B |
| Cohance Lifesciences | 174.24B |
| Alivus Life Sciences | 168.18B |
| Alembic Pharmaceuticals | 163.89B |
| NATCO Pharma | 145.10B |
| Sudeep Pharma | 132.20B |